Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

Profiling prostate tumours using single cell sequencing and computational prediction of drug targets

EF 2013-14

Résumé
Only 20-30% of cancer patients respond to drug treatments. Tumors are now known to be extensively heterogeneous and contain many different populations of cells, some of which will not respond to drugs. The advances in gene sequencing now make it possible to organize subpopulations of cells in tumors but the accuracy in dissecting and isolating different clones from tumors has been hindered by the lack of sophisticated network analysis tools. The construction of better clone-based networks clones would give a truer picture of tumor genetics and would aid in the identification of drug targets specific to the individual’s tumor type. By applying unique algorithms designed by us to dissect clones in prostate tumors, we would obtain unique information about certain receptors sitting on the surface of cells in each clone, thus constructing better clone-based networks. We would use this information to sort cells from patient prostate tumor samples according to the presence of their surface receptor. Once sorted we would analyze their genetic biomarkers and based on this data we would computationally predict drug targets for each clone. We have a catalog of gene biomarkers that are able to predict positive drug treatments in cancer cells. Thus the overall objective is to conduct a proof-of-concept study to treat prostate tumors in regards to what specific cells make up that clone.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
311846
Name
McGee Shauna R
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Profiling prostate tumours using single cell sequencing and computational prediction of drug targets
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bioinformatics; Cancer Heterogeneity; Computational Biology; Drug Targets; Genomics; Mouse Models; Systems Biology
Abstract
Only 20-30% of cancer patients respond to drug treatments. Tumors are now known to be extensively heterogeneous and contain many different populations of cells, some of which will not respond to drugs. The advances in gene sequencing now make it possible to organize subpopulations of cells in tumors but the accuracy in dissecting and isolating different clones from tumors has been hindered by the lack of sophisticated network analysis tools. The construction of better clone-based networks clones would give a truer picture of tumor genetics and would aid in the identification of drug targets specific to the individual’s tumor type. By applying unique algorithms designed by us to dissect clones in prostate tumors, we would obtain unique information about certain receptors sitting on the surface of cells in each clone, thus constructing better clone-based networks. We would use this information to sort cells from patient prostate tumor samples according to the presence of their surface receptor. Once sorted we would analyze their genetic biomarkers and based on this data we would computationally predict drug targets for each clone. We have a catalog of gene biomarkers that are able to predict positive drug treatments in cancer cells. Thus the overall objective is to conduct a proof-of-concept study to treat prostate tumors in regards to what specific cells make up that clone.
Competitiondate
201312
Approvedterm2
1 yr 0 mth
Pinamesdelim
McGee, Shauna R
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~